Applications of N-Chloroacetylglycine in Industrial Manufacturing

As a direct manufacturer, we supply N-Chloroacetylglycine to form critical intermediates and reagents for major chemical sectors. Downstream users incorporate our material into specialized processes, following precise industry guidelines and formulation protocols. Below we highlight key industrial application scenarios, including compliance standards, recommended usage ratios, integration points, and resulting final products manufactured using our N-Chloroacetylglycine.

1. Agrochemical Synthesis: Herbicide Intermediate Production

Agrochemical formulators use N-Chloroacetylglycine as a glycine derivative in the synthesis pathway for specific chloroacetanilide herbicides. The material reacts under controlled aqueous or organic conditions, typically via substitution processes, to give intermediates that undergo further modifications before final formulation. End-users track purity and byproduct profiles according to regional and international agrochemical pre-registration requirements, ensuring downstream pesticides comply with tolerance and residue legislation applicable to both export and domestic sales.

Industry compliance standards

• ISO 9001:2015 Quality Management System for agrochemical manufacturing
• FAO/WHO Codes of Conduct for Pesticide Management
• EU Regulation (EC) No 1107/2009 Plant Protection Products
• US EPA Active Ingredient Registration Requirements

Typical usage ratio

• 0.8 to 1.4 molar equivalents per target active ingredient batch
• Ratios adjusted based on expected side-reactions and batch scale

Downstream process integration

• Charged to primary reactor post-solubilization in pre-mix stage
• Monitored by HPLC or GC during intermediate formation
• Batch-wise addition to minimize uncontrolled exotherms

Final product types

• Pre-emergent herbicide active intermediates
• Formulated herbicide liquids and granules
• Technical grade agrochemical actives for blending
• Bulk registration samples for regulatory submission

2. Pharmaceutical Intermediate Manufacturing: β-Lactam Antibiotics

API producers integrate N-Chloroacetylglycine into multistep reactions to create β-lactam antibiotic intermediates. Strict control over batch traceability and impurity profile is required, with GMP documentation at all stages. The material enters coupling or acylation reactions that yield key β-lactam side chains, later processed via cyclization or hydrolysis. Downstream partners validate integration methods per pharmacopeial monograph and filing requirements within DMF or CEP procedures.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for API
• European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) chapters on β-lactam antibiotics
• US FDA DMF (Drug Master File) and EU CEP technical dossier
• Chinese Pharmacopoeia for domestic formulation

Typical usage ratio

• 1.00 to 1.06 equivalents per synthetic batch
• Scaled response based on starting precursor input and process validation data

Downstream process integration

• Dosed during side-chain formation step with close pH control
• Intermediate isolated via crystallization or extraction prior to final cyclization
• Sampled at mid-point for QC release by HPLC

Final product types

• β-lactam antibiotic pharmaceutical intermediates
• Pharmaceutical active ingredient blends
• Injectable-grade and oral β-lactam drug products
• Regulatory compliance reference standards

3. Fine Chemical Synthesis: Custom Reagents for Peptide Coupling

Peptide synthesis laboratories and fine chemical producers utilize N-Chloroacetylglycine as a protected amino acid derivative for generating N-chloroacetylated building blocks. Analytical release specifications focus on residual chloride, heavy metals, and chiral purity, as improper ratios can affect final peptide conformation. The reagent is most often applied in SPPS (solid phase peptide synthesis) or solution phase acylation, yielding protected peptides or custom intermediates for biotech R&D and small-scale drug discovery.

Industry compliance standards

• ISO 13485: Medical Device Quality Management for peptide reagents
• Sigma-Aldrich Analytical Reagent Specifications (for R&D use)
• cGMP guidelines for starting material traceability
• Reach Annex XVII (EU) for restricted chemicals in research

Typical usage ratio

• 0.9 to 1.2 molar equivalents per N-terminal amino function
• Batch adjustment based on resin loading or precursor availability

Downstream process integration

• Introduced during N-terminal acylation step following deprotection
• Purified by chromatography or preparative HPLC
• Intermediate sent to peptide mapping or MS validation

Final product types

• N-chloroacetylated peptide fragments
• Modified peptide APIs and research probes
• Synthetic vaccine antigens
• Custom fine chemical reagents for diagnostics

4. Specialty Polymer Additives: Modified Polyamide Precursors

Specialty polymer manufacturers employ N-Chloroacetylglycine as a functional monomer in producing modified polyamides for engineering plastics. The reagent’s unique reactivity allows controlled insertion of chloro-functional groups in the polycondensation stage, yielding polymers with improved flame retardancy and chemical resistance. Material handling protocols address potential byproduct formation and corrosion risk during melt phase or solution polymerization setups. Batch records correlate input ratio to final polymer molecular weight and desired physical properties.

Industry compliance standards

• ISO 14001: Environmental Management for chemical polymer production
• REACH (EC No 1907/2006) safety registration for monomer use
• UL 94 for flammability rating of finished polyamides
• RoHS 3 (EU) for restricted substance compliance in end plastics

Typical usage ratio

• 0.5–2.5% by weight of total monomer feed, precise level based on target polymer function
• Adjusted upward for application in flame-retardant or specialty barrier materials

Downstream process integration

• Added at initial monomer blend before polycondensation
• Monitored by GC-FID for consumption and side-product minimization
• Trace levels tracked in QC by FT-IR or NMR of final polymer

Final product types

• Flame-retardant polyamide engineering plastics
• Chemically resistant molded components
• High-barrier specialty films
• Technical-grade polymer compounds for automotive and electronics